title: Capreomycin in the treatment of atypical mycobacterial disease in HIV-positive patients.
authors.affiliation: Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany. goebels@med.uni-duesseldorf.de
authors.forename: K
authors.initials: K
authors.lastname: Göbels
authors.forename: J
authors.initials: J
authors.lastname: Hemker
authors.forename: M
authors.initials: M
authors.lastname: Oette
authors.forename: M
authors.initials: M
authors.lastname: Wettstein
authors.forename: T
authors.initials: T
authors.lastname: Heintges
authors.forename: D
authors.initials: D
authors.lastname: Teichmann
authors.forename: C R
authors.initials: CR
authors.lastname: MacKenzie
authors.forename: D
authors.initials: D
authors.lastname: Häussinger
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002207:Capreomycin / Q000627:therapeutic use*; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000382:microbiology; D006801:Humans; D008297:Male; D009161:Mycobacterium / Q000302:isolation & purification; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D002207:Capreomycin